These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24367840)

  • 21. Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center.
    Leary E; Brilliant M; Peissig P; Griesbach S
    Am J Health Syst Pharm; 2019 Feb; 76(6):387-397. PubMed ID: 31415684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring of anticoagulant therapy applying a dynamic statistical model.
    Nielsen PB; Lundbye-Christensen S; Larsen TB; Kristensen SR; Hejlesen OK
    Comput Methods Programs Biomed; 2013 Jun; 110(3):380-8. PubMed ID: 23305998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient factors that influence warfarin dose response.
    White PJ
    J Pharm Pract; 2010 Jun; 23(3):194-204. PubMed ID: 21507814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical applications of pharmacogenomics guided warfarin dosing.
    Mahajan P; Meyer KS; Wall GC; Price HJ
    Int J Clin Pharm; 2011 Feb; 33(1):10-9. PubMed ID: 21365388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials.
    Tang HL; Shi WL; Li XG; Zhang T; Zhai SD; Xie HG
    Pharmacogenomics J; 2015 Dec; 15(6):496-504. PubMed ID: 25869011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of genetic and nongenetic factors in warfarin dosing algorithms.
    Wu AH
    Pharmacogenomics; 2007 Jul; 8(7):851-61. PubMed ID: 18240910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.
    Liew A; Eikelboom JW; O'Donnell M; Hart RG
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S34-44. PubMed ID: 23790596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing for warfarin therapy initiation.
    Hynicka LM; Cahoon WD; Bukaveckas BL
    Ann Pharmacother; 2008 Sep; 42(9):1298-303. PubMed ID: 18682545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin.
    Kangelaris KN; Bent S; Nussbaum RL; Garcia DA; Tice JA
    J Gen Intern Med; 2009 May; 24(5):656-64. PubMed ID: 19306050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.
    Yanik MV; Irvin MR; Beasley TM; Jacobson PA; Julian BA; Limdi NA
    Pharmacotherapy; 2017 Nov; 37(11):1366-1373. PubMed ID: 28949423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing warfarin-related bleeding.
    Glasheen JJ
    South Med J; 2005 Jan; 98(1):96-103. PubMed ID: 15678642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio.
    Banet GA; Waterman AD; Milligan PE; Gatchel SK; Gage BF
    Chest; 2003 Feb; 123(2):499-503. PubMed ID: 12576372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International warfarin genotype-guided dosing algorithms in the Turkish population and their preventive effects on major and life-threatening hemorrhagic events.
    Karaca S; Bozkurt NC; Cesuroglu T; Karaca M; Bozkurt M; Eskioglu E; Polimanti R
    Pharmacogenomics; 2015; 16(10):1109-18. PubMed ID: 26216670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotype-guided dosing of warfarin through modeling and simulation.
    Deng J; Vozmediano V; Rodriguez M; Cavallari LH; Schmidt S
    Eur J Pharm Sci; 2017 Nov; 109S():S9-S14. PubMed ID: 28502675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial of initial warfarin dosing based on simple clinical criteria.
    Shine D; Patel J; Kumar J; Malik A; Jaeger J; Maida M; Ord L; Burrows G
    Thromb Haemost; 2003 Feb; 89(2):297-304. PubMed ID: 12574810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis of Randomized Controlled Trials of Genotype-Guided vs Standard Dosing of Warfarin.
    Dahal K; Sharma SP; Fung E; Lee J; Moore JH; Unterborn JN; Williams SM
    Chest; 2015 Sep; 148(3):701-710. PubMed ID: 25811981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paper-based dosing algorithms for maintenance of warfarin anticoagulation.
    Wilson SE; Costantini L; Crowther MA
    J Thromb Thrombolysis; 2007 Jun; 23(3):195-8. PubMed ID: 17186393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.